IOVANCE BIOTHERAPEUTICS, INC.
Income Statement
| Line Item | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 |
| Cost of Revenue | — | — | — | — | — |
| Gross Profit | — | — | — | — | — |
| Gross Margin | — | — | — | — | — |
| Operating Expenses | |||||
| Research & Development | $2.2M | $1.7M | $1.8M | $171.5K | $0 |
| SG&A Expense | $3.8M | — | — | — | — |
| Operating Income | $-22.6M | $-8.1M | $-21.2M | $-815.4K | $-15.8K |
| Operating Margin | — | — | — | — | — |
| Interest Expense | $444.7K | $1.9M | $151.5K | $0 | $0 |
| Pretax Income | — | — | — | — | — |
| Income Tax Expense | — | — | — | — | — |
| Net Income | $-25.4M | $-3.3M | $-25.7M | $-1.6M | $-15.8K |
| Net Margin | — | — | — | — | — |
| EPS (Basic) | $-3.47 | $-4.14 | $-0.34 | $-0.02 | $0.00 |
| EPS (Diluted) | $-3.47 | $-4.14 | $-0.34 | $-0.02 | $0.00 |
| Shares Outstanding (Basic) | 20.0M | 818.8K | 78.0M | 73.6M | — |
| Shares Outstanding (Diluted) | 20.0M | 818.8K | 78.0M | 73.6M | — |
| Dividends Per Share | — | — | — | — | — |